1 |
Increlex |
- |
- |
- |
- |
065 [4] 65, 78, 96, 299 💬 |
2 |
Increlex 10 mg/ml |
- |
- |
- |
- |
078 [1] 78 💬 |
3 |
Increlex 10 mg/ml, solución inyectable |
- |
- |
- |
- |
078 [1] 78 💬 |
4 |
Increlex 10mg/ml solution for injection |
- |
- |
- |
- |
096 [1] 96 💬 |
5 |
Increlex*sc 1fl 4ml 10mg/ml |
- |
- |
- |
- |
299 [1] 299 💬 |
6 |
Mecasermin |
Mecasermin |
[2] D03297 D03297, D04870 D04870 💬 |
GHR [2] GHR, IGF1R 💬 |
AMPK signaling pathway [33] AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
078 [5] 78, 96, 168, 265, 299 💬 |
7 |
Mecasermin [rdna origin] 10mg/ml solution |
Mecasermin |
[2] D03297 D03297, D04870 D04870 💬 |
GHR [2] GHR, IGF1R 💬 |
AMPK signaling pathway [33] AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
096 [1] 96 💬 |
8 |
Rhigf (increlex) |
- |
- |
- |
- |
096 [1] 96 💬 |